乐普医疗收盘下跌1.29%，滚动市盈率170.50倍，总市值244.86亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Lepu Medical, indicating a significant disparity between its price-to-earnings (PE) ratio and the industry average [1][2] - As of June 26, Lepu Medical's closing price was 13.02 yuan, with a rolling PE ratio of 170.50 times, significantly higher than the industry average of 49.45 times and the median of 35.92 times [1][2] - The total market capitalization of Lepu Medical is 24.486 billion yuan, ranking it 113th in the medical device industry based on PE ratio [1][2] Group 2 - The latest quarterly report for Q1 2025 shows that Lepu Medical achieved operating revenue of 1.736 billion yuan, a year-on-year decrease of 9.67%, and a net profit of 379 million yuan, down 21.44% year-on-year, with a gross profit margin of 64.03% [1] - As of March 31, 2025, Lepu Medical had 94,228 shareholders, an increase of 583 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares per shareholder [1]